Stay updated on Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Sign up to get notified when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.

Latest updates to the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears above the study page content.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer’s revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study content; this indicates access to the study record is blocked at this URL.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, blocking access to the record. This indicates a page access issue rather than a substantive update to the study information.SummaryDifference18%

- Check57 days agoChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6, indicating a small update to the page infrastructure. No core content or study data appear to be affected.SummaryDifference0.1%

Stay in the know with updates to Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.